MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 109 filers reported holding MEI PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $132,000 | -75.9% | 50,000 | -71.5% | 0.08% | -84.1% |
| Q3 2020 | $548,000 | -55.1% | 175,560 | -40.6% | 0.52% | -59.9% |
| Q2 2020 | $1,221,000 | -14.4% | 295,560 | -66.6% | 1.29% | -17.3% |
| Q1 2020 | $1,426,000 | -32.0% | 885,560 | +4.7% | 1.56% | -22.9% |
| Q4 2019 | $2,097,000 | +47.6% | 845,560 | 0.0% | 2.02% | +26.3% |
| Q3 2019 | $1,421,000 | -73.0% | 845,560 | -59.8% | 1.60% | -73.2% |
| Q2 2019 | $5,254,000 | -50.5% | 2,101,533 | -39.2% | 5.97% | -39.5% |
| Q1 2019 | $10,620,000 | +16.3% | 3,459,124 | 0.0% | 9.86% | -11.0% |
| Q4 2018 | $9,132,000 | -42.4% | 3,459,124 | -6.0% | 11.08% | -24.4% |
| Q3 2018 | $15,855,000 | -8.6% | 3,678,600 | -16.4% | 14.66% | +139.2% |
| Q2 2018 | $17,338,000 | – | 4,400,439 | – | 6.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 3,459,124 | $9,132,000 | 11.08% |
| Sio Capital Management, LLC | 2,373,841 | $6,267,000 | 2.28% |
| Vivo Capital, LLC | 5,778,106 | $15,254,000 | 1.95% |
| BVF INC/IL | 2,978,708 | $7,864,000 | 1.03% |
| Boxer Capital, LLC | 2,913,091 | $7,691,000 | 0.95% |
| NEA Management Company, LLC | 5,720,572 | $15,102,000 | 0.60% |
| Perceptive Advisors | 4,400,440 | $11,617,000 | 0.44% |
| INDUS CAPITAL PARTNERS, LLC | 631,513 | $1,667,000 | 0.30% |
| BAILARD, INC. | 381,292 | $1,007,000 | 0.07% |
| KNOTT DAVID M | 38,590 | $102,000 | 0.05% |